These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6003362)

  • 1. [Innovation, originality and utility of patent rights with special reference to drugs and in relation to the last bill].
    Banci F
    Boll Chim Farm; 1966 Aug; 105(8):570-4. PubMed ID: 6003362
    [No Abstract]   [Full Text] [Related]  

  • 2. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP; Deng MM
    Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract]   [Full Text] [Related]  

  • 3. Off-patent drugs in Italy. A short-sighted view?
    Garattini L; Ghislandi S
    Eur J Health Econ; 2006 Mar; 7(1):79-83. PubMed ID: 16425040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IP litigation in China could drive innovation.
    Jia H
    Nat Biotechnol; 2004 Apr; 22(4):368. PubMed ID: 15060539
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of patent term restoration to pharmaceutical innovation.
    Huntt PB
    Health Aff (Millwood); 1982; 1(2):6-24. PubMed ID: 10324213
    [No Abstract]   [Full Text] [Related]  

  • 6. [Patent rights on drugs: what others are doing].
    Banci F
    Boll Chim Farm; 1968 Nov; 107(11):661-3. PubMed ID: 5729791
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationships between the academic community and the pharmaceutical industry: the legislative background and its effect on spending on medical research and development.
    Matthews JH
    Clin Invest Med; 1996 Dec; 19(6):470-8. PubMed ID: 8959357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.
    Rai AK
    Univ Ill Law Rev; 2001; 2001(1):173-210. PubMed ID: 16493845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 10. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of patents for the qualitative level in the evaluation of drugs].
    Rovati AL
    Boll Chim Farm; 1971 Oct; 110(10):569-72. PubMed ID: 5143354
    [No Abstract]   [Full Text] [Related]  

  • 12. [Latest status of the drug patent law].
    Banci F
    Boll Chim Farm; 1970 Dec; 109(12):699-701. PubMed ID: 5521480
    [No Abstract]   [Full Text] [Related]  

  • 13. Global health and university patents.
    Kapczynski A; Crone ET; Merson M
    Science; 2003 Sep; 301(5640):1629. PubMed ID: 14500943
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent watch: extra exclusivity for new medical uses.
    Harrison C
    Nat Rev Drug Discov; 2012 Sep; 11(9):666. PubMed ID: 22935795
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bill on the patentability of drugs and requirements of the researchers].
    Cingolani E
    Farmaco Prat; 1966 Nov; 21(11):621-4. PubMed ID: 5992985
    [No Abstract]   [Full Text] [Related]  

  • 16. [The status of a nonpatented drug of which the basic molecule in patented].
    Petranker L; Stenger J
    Ann Pharm Fr; 1975 Nov; 33(11):619-25. PubMed ID: 1231608
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of patent term restoration to pharmaceutical innovation.
    Hutt PB
    Health Aff (Millwood); 1982; 1(2):6-24. PubMed ID: 7185724
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmaceutical patents and the accessibility of drugs in Brazil].
    Marques MB
    Hist Cienc Saude Manguinhos; 2000; 7(1):7-21. PubMed ID: 11625765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 20. [Patents in the pharmaceutical field: history and development of the institution].
    Neri M
    Boll Chim Farm; 1995; 134(7):364-8. PubMed ID: 7546541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.